Shanghai No.1 Pharmacy Co Ltd operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai No.1 Pharmacy Co Ltd with three other
drug stores in Asia:
Apex Healthcare Bhd
sales of 688.79 million Malaysian Ringgits [US$163.03 million]
of which 91%
was Wholesale and Distribution),
Sapporo Clinical Laboratory Inc.
(17.07 billion Japanese Yen [US$161.10 million]
Zhongzhi Pharmaceutical Holdings Ltd
based in HONG KONG
(1.52 billion Hong Kong Dollars [US$196.64 million]
of which 56%
was Pharmaceutical manufacturing).
During the year ended December of 2019, sales at
Shanghai No.1 Pharmacy Co Ltd were 1.24 billion Chinese Renmimbi (US$178.08 million).
increase of 5.7%
versus 2018, when the company's sales were 1.18 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2017, when Shanghai No.1 Pharmacy Co Ltd
reported sales of 1.56 billion Chinese Renmimbi.
Sales of Other Operation saw an increase
7.7% in 2019, from
55.12 million Chinese Renmimbi to 59.35 million Chinese Renmimbi.